Childhood Allergy and Asthma Development Mechanisms

Childhood allergy and asthma arise from a complex interplay of genetic predisposition, immune system maturation and environmental exposures. Early life represents a critical window during which innate immune cells and barrier functions of the respiratory mucosa evolve, shaping subsequent adaptive responses. A skew towards type 2 helper T cell immunity, characterised by elevated interleukins such as IL-4, IL-5 and IL-13, underpins allergic sensitisation and eosinophilic inflammation. Impaired integrity of the airway epithelium facilitates allergen penetration and dysregulated release of alarmins, such as thymic stromal lymphopoietin, further promoting a pro-allergic milieu. Environmental factors, including exposure to pollutants, microbial communities and common childhood infections, can modulate immune trajectories through epigenetic modifications and microbial colonisation patterns. Maternal influences during gestation, ranging from systemic inflammation to nutritional status, imprint on foetal immune development and ncRNA expression, establishing a baseline risk for atopic disorders. The interplay between genetic variants in immunoregulatory genes, early-life microbial diversity, and repeated antigen encounters determines whether immune tolerance or allergic inflammation predominates. Understanding these mechanisms is essential for the design of preventive strategies, such as maternal interventions, microbial-based therapies and targeted immunomodulation, to reduce the global burden of paediatric allergic disease and asthma.

Research from Nature Portfolio

Recent studies have revealed that systemic low-grade inflammation during pregnancy correlates with inflammatory markers measured in infants at six months of age, independent of maternal body mass index, environmental exposures and genetic risk factors. This work highlights how maternal inflammatory status may program offspring immune responses and contribute to heightened susceptibility to asthma and allergy in early childhood, emphasising the importance of monitoring and modulating maternal inflammation as a preventive approach.

Childhood Allergy and Asthma Development Mechanisms publication trend

The graph below shows the total number of articles in childhood allergy and asthma development mechanisms across all publications each year (not limited to Nature Index journals).

Technical terms

Atopy: The genetic tendency to develop allergic hypersensitivity responses to common environmental antigens.

Eosinophil: A type of white blood cell involved in allergic inflammation and defence against parasitic infections.

Th2 immune response: A pattern of adaptive immunity driven by type 2 helper T cells that promotes antibody production and eosinophil activation.

Alarmins: Epithelial-derived cytokines released upon tissue injury or allergen exposure that initiate immune responses.

Epigenetic modification: Heritable changes in gene expression without alteration of the DNA sequence, often influenced by environmental factors.

Microbiota: The community of microorganisms residing in the respiratory or gastrointestinal tract that modulates host immunity.

References

1. Key risk factors of asthma-like symptoms are mediated through infection burden in early childhood. Journal of Allergy and Clinical Immunology (2023).
2. Maternal imprinting and determinants of neonates’ immune function in the SEPAGES mother-child cohort. Frontiers in Immunology (2023).
3. Postnatal Innate Immune Development: From Birth to Adulthood. Frontiers in Immunology (2017).
4. Levels of Systemic Low-grade Inflammation in Pregnant Mothers and Their Offspring are Correlated. Scientific Reports (2019).
5. Prenatal exposure to ambient air pollution is associated with early life immune perturbations. Journal of Allergy and Clinical Immunology (2022).
6. Blood eosinophil related to maternal allergic rhinitis is associated with the incidence of allergic rhinitis in offspring: COCOA study. BMC Pediatrics (2023).
7. Clinical Significance of Combined Detection of CCL22 and IL‐1 as Potential New Bronchial Inflammatory Mediators in Children's Asthma. Immunity Inflammation and Disease (2024).